As guidance on the wastage provision in last year’s infrastructure package draws closer, expected in the annual rule-cycle, ADVI SAVEs analyzed Medicare Part B drug discarded unit trends and found a 132% increase in the number of drugs above the 10% threshold over the past 5 years. We take a closer look at which products, […]
Read moreOur work to evaluate potential strategies to implement Combination Pricing and understand impact to ASP.
Read moreOur work to prepare manufacturer marketing and field teams for successful local Part B launch with Medicare Administrative Contractors (MACs).
Read moreOur work to better prepare executive team for drug pricing and value debate, assisting in training field-based personnel on customer reimbursement/pricing/value questions.
Read more